$DYAI
Dyadic International Inc Stock $dyai

$dyai Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000143774922026889 Filed on November 10, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$743.7K	$879.6K	$692.9K
YoY Change	137.39%	26.94%	66.43%
Cost Of Revenue	$704.5K	$602.8K	$392.5K
YoY Change	112.43%	53.57%	47.06%
Gross Profit	$39.24K	$276.8K	$300.4K
YoY Change	-313.96%	-7.87%	101.02%
Gross Profit Margin	5.28%	31.46%	43.35%
Selling, General & Admin	$1.668M	$1.383M	$1.693M
YoY Change	-2.04%	-18.28%	3.22%
% of Gross Profit	4251.63%	499.88%	563.56%
Research & Development	$584.1K	$743.6K	$1.902M
YoY Change	-76.38%	-60.9%	92.84%
% of Gross Profit	1488.58%	268.68%	633.04%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.252M	$743.6K	$1.902M
YoY Change	-46.07%	-60.9%	92.84%
Operating Profit	-$2.213M	-$1.863M	-$3.324M
YoY Change	-47.24%	-43.94%	29.02%
Interest Expense	$316.8K	$54.30K	$3.202K
YoY Change	-80.03%	1595.82%	-95.83%
% of Operating Profit
Other Income/Expense, Net	-$250.0K	$54.30K	$1.609M
YoY Change	-84.43%	-96.62%	1994.46%
Pretax Income	-$2.146M	-$1.809M	-$1.715M
YoY Change	-49.06%	5.47%	-31.39%
Income Tax
% Of Pretax Income
Net Earnings	-$2.146M	-$1.809M	-$1.715M
YoY Change	-49.06%	5.47%	-31.38%
Net Earnings / Revenue	-288.6%	-205.68%	-247.54%
Basic Earnings Per Share		-$0.06	-$0.06
Diluted Earnings Per Share	-$0.08	-$63.72K	-$61.09K
COMMON SHARES
Basic Shares Outstanding	28.56M	28.42M	28.08M
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.64M	$14.20M	$22.75M
YoY Change	-37.6%	-37.57%	-25.2%
Cash & Equivalents	$5.794M	$6.739M	$13.66M
Short-Term Investments	$6.847M	$7.462M	$9.087M
Other Short-Term Assets	$392.2K	$448.2K	$570.0K
YoY Change	4.37%	-21.36%	35.71%
Inventory
Prepaid Expenses
Receivables	$330.0K	$235.4K	$179.6K
Other Receivables	$58.29K	$43.87K	$74.80K
Total Short-Term Assets	$13.42M	$14.93M	$23.57M
YoY Change	-36.11%	-36.67%	-25.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$284.7K	$284.7K	$284.7K
YoY Change	0.0%	0.0%
Other Assets	$6.045K	$6.003K	$6.143K
YoY Change	-1.18%	-2.28%	10.53%
Total Long-Term Assets	$290.8K	$290.7K	$290.9K
YoY Change	-0.02%	-0.05%	5133.03%
TOTAL ASSETS
Total Short-Term Assets	$13.42M	$14.93M	$23.57M
Total Long-Term Assets	$290.8K	$290.7K	$290.9K
Total Assets	$13.71M	$15.22M	$23.86M
YoY Change	-35.62%	-36.22%	-24.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.276M	$777.2K	$957.8K
YoY Change	-17.55%	-18.85%	-1.94%
Accrued Expenses	$955.1K	$987.9K	$842.5K
YoY Change	34.6%	17.26%	35.74%
Deferred Revenue	$40.74K	$445.0K	$162.7K
YoY Change	-73.04%	173.57%	5.74%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.449M	$2.387M	$1.963M
YoY Change	-4.19%	21.59%	12.09%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$176.5K	$220.6K
YoY Change	-50.0%
Total Long-Term Liabilities	$176.5K	$220.6K	$0.00
YoY Change	-50.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.449M	$2.387M	$1.963M
Total Long-Term Liabilities	$176.5K	$220.6K	$0.00
Total Liabilities	$2.625M	$2.607M	$1.963M
YoY Change	-9.75%	32.82%	12.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$73.48M	-$71.34M	-$59.53M
YoY Change	15.27%	19.83%	22.2%
Common Stock	$40.82K	$40.72K	$40.33K
YoY Change	0.83%	0.95%	1.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$18.90M	$18.93M	$18.90M
YoY Change	-0.16%	0.16%	0.0%
Treasury Stock Shares
Shareholders Equity	$11.09M	$12.61M	$21.90M
YoY Change
Total Liabilities & Shareholders Equity	$13.71M	$15.22M	$23.86M
YoY Change	-35.62%	-36.22%	-24.83%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$2.146M	-$1.809M	-$1.715M
YoY Change	-49.06%	5.47%	-31.38%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.682M	-$1.776M	-$4.334M
YoY Change	-36.18%	-59.02%	211.81%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$617.9K	-$1.310M	$4.006M
YoY Change	-86.27%	-132.7%	-65.02%
Cash From Investing Activities	$617.9K	-$1.310M	$4.006M
YoY Change	-86.27%	-132.7%	-65.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	141.5K	359.7K	-590.0
YoY Change	-42.13%	-61072.88%
NET CHANGE
Cash From Operating Activities	-1.682M	-1.776M	-4.334M
Cash From Investing Activities	617.9K	-1.310M	4.006M
Cash From Financing Activities	141.5K	359.7K	-590.0
Net Change In Cash	-922.4K	-2.726M	-329.2K
YoY Change	-143.73%	728.29%	-103.27%
FREE CASH FLOW
Cash From Operating Activities	-$1.682M	-$1.776M	-$4.334M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40716602
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40482659
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28463100
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28229157
CY2022Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021	dyai	Deferred Tax Assets Valuation Allowance Coverage Percent DeferredTaxAssetsValuationAllowanceCoveragePercent	1	pure
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5281097
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4824215
CY2021	dyai	Research And Development Expense Related Party ResearchAndDevelopmentExpenseRelatedParty	0	usd
CY2017Q2	dyai	Collaborative Arrangement Payment For Research And Development Agreement CollaborativeArrangementPaymentForResearchAndDevelopmentAgreement	1000000.0	eur
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6003	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	43873	usd
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	94375	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	235368	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	277831	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	448208	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	375830	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	14928450	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	21008296	usd
CY2022Q3	dyai	Prepaid Research And Development In Process Current PrepaidResearchAndDevelopmentInProcessCurrent	284709	usd
CY2021Q4	dyai	Prepaid Research And Development In Process Current PrepaidResearchAndDevelopmentInProcessCurrent	284709	usd
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55264
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-0486747
	dei	Entity Address Address Line1 EntityAddressAddressLine1	140 Intracoastal Pointe Drive, Suite 404
	dei	Entity Address City Or Town EntityAddressCityOrTown	Jupiter
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33477
	dei	City Area Code CityAreaCode	561
	dei	Local Phone Number LocalPhoneNumber	743-8333
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	DYAI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28563100
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6739117	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15748480	usd
CY2022Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	7461884	usd
CY2021Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4511780	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6117	usd
CY2022Q3	us-gaap	Assets Assets	15219162	usd
CY2021Q4	us-gaap	Assets Assets	21299122	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	777238	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1547953	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	987891	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	709560	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	445044	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	151147	usd
CY2022Q3	dyai	Deferred License Revenue Current DeferredLicenseRevenueCurrent	176471	usd
CY2021Q4	dyai	Deferred License Revenue Current DeferredLicenseRevenueCurrent	147059	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2386644	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2555719	usd
CY2022Q3	dyai	Deferred License Revenue Net Of Current Portion DeferredLicenseRevenueNetOfCurrentPortion	220588	usd
CY2021Q4	dyai	Deferred License Revenue Net Of Current Portion DeferredLicenseRevenueNetOfCurrentPortion	352941	usd
CY2022Q3	us-gaap	Liabilities Liabilities	2607232	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2908660	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1692837	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4753162	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4994458	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-13205	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	28391894
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-30002	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-23578	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-76080	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	2743070	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	4016931	usd
	us-gaap	Costs And Expenses CostsAndExpenses	10112687	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	40717	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	40483	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	102836563	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	101026496	usd
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-71335435	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63746602	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	12611930	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	18390462	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15219162	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21299122	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	879597	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	692929	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2186577	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2090541	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	602847	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	392544	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1418702	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1612810	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	743585	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1901548	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3917245	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5918888	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1383433	usd
	us-gaap	Costs And Expenses CostsAndExpenses	12602236	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1863473	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3324002	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7926110	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10511695	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	54300	usd
CY2021Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3202	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	87277	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	49772	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1605532	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	250000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1605532	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	54300	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1608734	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	337277	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1655304	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1809173	usd
CY2021Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	28079157
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1715268	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7588833	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8856391	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	37094	usd
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	254193	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-0	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	1605532	usd
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	28302332
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	27754597
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	18390462	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	453791	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	42350	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2491665	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	16394938	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	454500	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3287995	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13561443	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	499919	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	359741	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1809173	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	12611930	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	28446561	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	421071	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	115800	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-3294949	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	25688483	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	446120	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	870340	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-3846174	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	23158769	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	457209	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-590	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1715268	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	21900120	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7588833	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8856391	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1408210	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1324400	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-23579	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-76081	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-50502	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-37454	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14837	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-72051	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	70051	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	289481	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-716964	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-47033	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	278331	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	352713	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	293897	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	39664	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-102941	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6402013	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8641881	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	8487198	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	11283940	usd
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	5500000	usd
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	10400000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	0	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	1605532	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2987198	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	721592	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	402091	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	985550	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	402091	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	985550	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-22243	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-41695	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9009363	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6976434	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15748480	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20637045	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6739117	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13660611	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of these consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amount of assets and liabilities and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the applicable period. Actual results <em style="font: inherit;"> may </em>differ from these estimates under different assumptions or conditions. Such differences could be material to the consolidated financial statements.</p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"><b><i>Concentrations and Credit Risk</i></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Company’s financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash and cash equivalents, investment securities, and accounts receivable. At times, the Company has cash, cash equivalents, and investment securities at financial institutions exceeding the Federal Depository Insurance Company (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”) insured limit on domestic currency and the Netherlands’ FDIC counterpart for foreign currency. The Company only deals with reputable financial institutions and has <em style="font: inherit;">not</em> experienced any losses in such accounts.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">For each of the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2022 </em>and <em style="font: inherit;">2021</em>, the Company's revenue was generated from eight customers. For each of the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2022 </em>and <em style="font: inherit;">2021</em>, the Company’s revenue was generate<span style="background-color:#ffffff;">d from thirteen customers. As of </span><em style="font: inherit;"> September 30, 2022</em><span style="background-color:#ffffff;"> and </span><em style="font: inherit;"> December 31, 2021</em><span style="background-color:#ffffff;">, the Company’s accounts receivable was from four</span><span style="background-color:#ffffff;"> and eight customers, respectively. The loss of business from <em style="font: inherit;">one</em> or a combination of the Company’s customers could adversely affect its operations.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><span style="background-color:#ffffff;">The Company conducts operations in the Netherlands through its foreign subsidiary and generates a portion of its revenues from customers that are located outside of the United States. For the <em style="font: inherit;">three</em> months ended </span><em style="font: inherit;"> September 30, 2022 </em>and <em style="font: inherit;">2021</em><span style="background-color:#ffffff;">, the Company had </span>four<span style="background-color:#ffffff;"> and </span>five<span style="background-color:#ffffff;"> customers outside of the United States (i.e., European and Asian customers) that accounted for approximately </span>$133,000<span style="background-color:#ffffff;"> or </span>16.0%<span style="background-color:#ffffff;"> and </span>$478,000<span style="background-color:#ffffff;"> or </span>69.1%<span style="background-color:#ffffff;"> of the revenue, respectively. For the </span><em style="font: inherit;">nine</em><span style="background-color:#ffffff;"> months ended </span><em style="font: inherit;"> September 30, 2022 </em>and <em style="font: inherit;">2021</em><span style="background-color:#ffffff;">, the Company had </span>six<span style="background-color:#ffffff;"> and </span>seven<span style="background-color:#ffffff;"> customers outside of the United States that accounted for approximately </span>$509,000<span style="background-color:#ffffff;"> or </span>25.6%<span style="background-color:#ffffff;"> and </span>$1,599,000<span style="background-color:#ffffff;"> or </span>76.5%<span style="background-color:#ffffff;"> of the revenue, respectively. </span></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><span style="background-color:#ffffff;">As of </span><em style="font: inherit;"> September 30, 2022</em><span style="background-color:#ffffff;">, the Company had </span>two<span style="background-color:#ffffff;"> customers outside of the United States (i.e., European and Asian customers) that accounted for approximately </span>$43,000<span style="background-color:#ffffff;"> or </span>17.8%<span style="background-color:#ffffff;"> of accounts receivable. As of </span><em style="font: inherit;"> December 31, 2021</em><span style="background-color:#ffffff;">, the Company had four customers outside of the United States that accounted for approximately </span>$157,000<span style="background-color:#ffffff;"> or </span>56.4%<span style="background-color:#ffffff;"> of accounts receivable.</span></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-indent: 36pt; text-align: justify;"><span style="background-color:#ffffff;">The Company uses several contract research organizations (“CROs”) to conduct its research projects. For the <em style="font: inherit;">three</em> months ended </span><em style="font: inherit;"> September 30, 2022 </em>and <em style="font: inherit;">2021</em><span style="background-color:#ffffff;">, </span>three<span style="background-color:#ffffff;"> and two </span><span style="background-color:#ffffff;">CROs accounted for approximately </span>$1,352,000<span style="background-color:#ffffff;"> or </span>99.5%<span style="background-color:#ffffff;"> and </span>$1,982,000<span style="background-color:#ffffff;"> or </span>97.2%<span style="background-color:#ffffff;"> of total research services we purchased, respectively. For the <em style="font: inherit;">nine</em> months ended </span><em style="font: inherit;"> September 30, 2022 </em>and <em style="font: inherit;">2021</em><span style="background-color:#ffffff;">, </span>three<span style="background-color:#ffffff;"> </span><span style="background-color:#ffffff;">CROs accounted for approximately $4,146,000 </span><span style="background-color:#ffffff;">or 97.4% </span><span style="background-color:#ffffff;">and </span>$6,621,000<span style="background-color:#ffffff;"> or </span>96.9%<span style="background-color:#ffffff;"> of total research services we purchased, respectively. As of </span><em style="font: inherit;"> September 30, 2022</em><span style="background-color:#ffffff;"> and </span><em style="font: inherit;"> December 31, 2021</em><span style="background-color:#ffffff;">, three and two CROs accounted for approximately $714,000 </span><span style="background-color:#ffffff;">or 91.9% </span><span style="background-color:#ffffff;">and $1,312,000 or 84.8% of the accounts payable, respectively. The loss of <em style="font: inherit;">one</em> CRO or a combination of the Company’s CROs could adversely affect its operations.</span></p>
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	235368	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	277831	usd
CY2021Q3	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	174856000	usd
	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	593258000	usd
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	382045	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	326712	usd
CY2022Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	55075	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	45839	usd
CY2022Q3	dyai	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	10920	usd
CY2021Q4	dyai	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	0	usd
CY2022Q3	us-gaap	Prepaid Taxes PrepaidTaxes	168	usd
CY2021Q4	us-gaap	Prepaid Taxes PrepaidTaxes	3279	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	448208	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	375830	usd
	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	472605000	usd
CY2022Q3	dyai	Research And Development Expense Facilities Overhead And Other ResearchAndDevelopmentExpenseFacilitiesOverheadAndOther	5842000	usd
CY2021Q3	dyai	Research And Development Expense Facilities Overhead And Other ResearchAndDevelopmentExpenseFacilitiesOverheadAndOther	26412000	usd
	dyai	Research And Development Expense Facilities Overhead And Other ResearchAndDevelopmentExpenseFacilitiesOverheadAndOther	21076000	usd
	dyai	Research And Development Expense Facilities Overhead And Other ResearchAndDevelopmentExpenseFacilitiesOverheadAndOther	50056000	usd
CY2022Q3	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	725216	usd
CY2021Q4	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	1363889	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	17616	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	27675	usd
CY2022Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	34406	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	156389	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	777238	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1547953	usd
CY2022Q3	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	743585000	usd
CY2022Q3	dyai	Accrued Research And Development In Process Current AccruedResearchAndDevelopmentInProcessCurrent	634951	usd
CY2021Q4	dyai	Accrued Research And Development In Process Current AccruedResearchAndDevelopmentInProcessCurrent	194250	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	258130	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	405758	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	94810	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	109552	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	987891	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	709560	usd
CY2021Q3	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	1901548000	usd
	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	3917245000	usd
CY2022Q3	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	550750000	usd
CY2021Q3	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	1700280000	usd
	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	3302911000	usd
	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	5396227000	usd
CY2022Q3	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	186993000	usd
	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	5918888000	usd
CY2021Q4	dyai	Cash Cash Equivalents And Investments Fair Value CashCashEquivalentsAndInvestmentsFairValue	20257765	usd
CY2021Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	2495	usd
CY2021Q4	us-gaap	Investments And Cash InvestmentsAndCash	20260260	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5281097
CY2021Q4	dyai	Upfront Payment Payable UpfrontPaymentPayable	500000	usd
CY2021Q4	dyai	Number Of Performance Obligations NumberOfPerformanceObligations	2	pure
CY2017Q2	dyai	Collaborative Arrangement Payment For Research And Development Agreement CollaborativeArrangementPaymentForResearchAndDevelopmentAgreement	1100000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	15700000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13000000.0	usd
	dyai	Deferred Tax Assets Valuation Allowance Coverage Percent DeferredTaxAssetsValuationAllowanceCoveragePercent	1	pure
CY2022Q3	us-gaap	Investments And Cash InvestmentsAndCash	14201001	usd
CY2021Q4	us-gaap	Cash Cash	1377094	usd
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	14371386	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	15748480	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15748480	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4824215
CY2022Q3	us-gaap	Cash Cash	654971	usd
CY2022Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	6084146	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	6739117	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6739117	usd
CY2022Q3	dyai	Cash Cash Equivalents And Investments Fair Value CashCashEquivalentsAndInvestmentsFairValue	14137017	usd
CY2022Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	63984	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5281097
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.27
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M19D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	770536	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3876280
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.85
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	50000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.22
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	75000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.81
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4774215
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.04
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M20D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8413444	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	865825
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.43
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	233943
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.72
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	766446	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	499919	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	457209	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1408210	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1324400	usd
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001

Files In Submission

Name	View Source	Status
dyai-20220930_cal.xml	Edgar Link	unprocessable
0001437749-22-026889-index-headers.html	Edgar Link	pending
0001437749-22-026889-index.html	Edgar Link	pending
0001437749-22-026889.txt	Edgar Link	pending
0001437749-22-026889-xbrl.zip	Edgar Link	pending
dyai-20200930_g1copy.jpg	Edgar Link	pending
dyai-20220930.xsd	Edgar Link	pending
dyai20220930_10q.htm	Edgar Link	pending
ex_412419.htm	Edgar Link	pending
ex_412420.htm	Edgar Link	pending
ex_412421.htm	Edgar Link	pending
ex_412422.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
dyai-20220930_def.xml	Edgar Link	unprocessable
dyai-20220930_lab.xml	Edgar Link	unprocessable
dyai-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
dyai20220930_10q_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DYAI
Dyadic International Inc Stock $dyai

2022 Q4 Form 10-Q Financial Statement

#000143774922026889 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI Dyadic International Inc Stock $dyai

2022 Q4 Form 10-Q Financial Statement

#000143774922026889 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI
Dyadic International Inc Stock $dyai